Bringing the fundamentals into focus…
Back to Rigel Pharmaceuticals, Inc.
How Rigel Pharmaceuticals, Inc. stacks up
RIGL · against 454 other Healthcare companies listed in US-listed
Growth
88/ 100
Near the top of its peers.
Ranked #91 of 455 · scores higher than 79% of peers
Bars: peers in each 10-point band of the growth score66 peers with a growth score of 80–89, including RIGL · Click a bar to see the companies
Why growth scores 88?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings per share growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- Revenue growth is close to the peer norm. Revenue growth: 3.3% vs peer median 6.1%
- faster revenue growth over three years: stronger than 88% of peers. 3-year revenue growth: 29.8% vs peer median 5.8%
- faster growth in earnings per share: stronger than 93% of peers. Earnings per share growth: 216.0% vs peer median 9.8%
Metric by metric
Position: dot = RIGL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RIGL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 3.3% | 11.0% | 29% | 33% | |
| Earnings per share growthHigher is better · 171 reported | 216.0% | 21.2% | 86% | 33% | |
| 3-year revenue growthHigher is better · 433 reported | 29.8% | 11.0% | 78% | 33% |
Ranking by growth score
Top 5 and the companies ranked around RIGL| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 91 | 782M USD | 88 | 35 | |
| 91 | 4.3B USD | 88 | 69 | |
| 91 | 110M USD | 88 | 54 | |
| 91 | 421M USD | 88 | 52 | |
| 91 | 913M USD | 88 | 77 | |
| 91 | 4.6B USD | 88 | 61 | |
| 91 | 1.3B USD | 88 | 58 | |
| 91 | 14.0B USD | 88 | 31 | |
| 99 | 1.9B USD | 87 | 68 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score